Intermediate for Efinaconazole. Efinaconazole (trade names: Jublia and Clenafin) is a 14α-demethylase inhibitor for the treatment of onychomycosis (fungal infection of the nail). Efinaconazole has been approved by the U.S Food and Drug Administration on June 6, 2014.


Product Name:                  (2R)-1-(2,4-Difluorophenyl)-2-((tetrahydro-2H-pyran-2-yl)oxy)propan-1-one

Synonyms:                         N/A

CAS Number:                     126918-17-0

Molecular Weight:            270.2754

Molecular Formula:          C14H16F2O3

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               FC1=CC(F)=C(C([C@@H](C)OC2OCCCC2)=O)C=C1


  • $346.00
  • Ex Tax: $346.00

Available Options